What are the risks of taking Mifegyne in early pregnancy but continuing the pregnancy?
Abstract
Continuing a pregnancy after Mifepristone exposure may pose risks such as congenital anomalies and increased need for medical intervention, though the specific risk from Mifepristone alone remains uncertain due to limited and mixed evidence.
Fields of Study & Subjects
Reproductive Health and Contraception
Pregnancy and Medication Impact
Pharmacological Effects and Toxicity Studies
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 4 February 2026